Evidence map›Paper›PMID 34131251›Full record

ArticleScientific reports2021

Syntheses of mono-acylated luteolin derivatives, evaluation of their antiproliferative and radical scavenging activities and implications on their oral bioavailability.

Stephen Lo, Euphemia Leung, Bruno Fedrizzi, David Barker

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. New Steroids Obtained fromMolecules (Basel, Switzerland) · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Stephen LoSchool of Chemical Sciences, University of Auckland, 23 Symonds St, Auckland, 1010, New Zealand.
Euphemia LeungAuckland Cancer Society Research Centre, University of Auckland, Auckland, 1023, New Zealand.
Bruno FedrizziSchool of Chemical Sciences, University of Auckland, 23 Symonds St, Auckland, 1010, New Zealand.
David BarkerSchool of Chemical Sciences, University of Auckland, 23 Symonds St, Auckland, 1010, New Zealand. d.barker@auckland.ac.nz.
University of Auckland · NZCancer Society of New Zealand · NZMacDiarmid Institute for Advanced Materials and Nanotechnology · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Luteolin is a flavonoid found in a wide range of plant materials, including commonly eaten fruits and vegetables. It displays a wide range of biological activities but is known to have poor bioavailability. In this study, ten different mono-acyl (nine 5-O-acyl and one 7-O-acyl) derivatives of luteolin were synthesised for the purpose of improving bioactivity and bioavailability, and therefore enhance their therapeutic potential. The antiproliferative activity of these derivatives was assessed against the HCT116 colon cancer and MDA-MB-231 breast cancer cell lines using a

Indexed as

Biological AvailabilityAntioxidantsBreast NeoplasmsColonic NeoplasmsFemaleFree Radical ScavengersHCT116 CellsHumansLuteolinAntioxidantsFree Radical ScavengersLuteolin

Identifiers

PMID34131251
PMCPMC8206097
OpenAlexW3169315103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.